The present invention relates to compounds or pharmaceutically-acceptable salts thereof, processes for preparing them, pharmaceutical compositions containing them and their use in therapy. The invention particularly relates to compounds that are polo-like kinase (PLKs) inhibitors useful for the treatment of disease states mediated by PLK, especially PLK4, in particular such compounds that are useful in the treatment of pathological processes which involve an aberrant cellular proliferation, such as tumour growth, rheumatoid arthritis, restenosis and atherosclerosis.
Diaminotriazoles useful as inhibitors of protein kinases
申请人:——
公开号:US20040214817A1
公开(公告)日:2004-10-28
The present invention relates to inhibitors of protein kinases. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.
DIAMINOTRIAZOLES USEFUL AS INHIBITORS OF PROTEIN KINASES
申请人:Pierce C. Albert
公开号:US20080014189A1
公开(公告)日:2008-01-17
The present invention relates to inhibitors of protein kinases. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.